SEC Filing Document

Company: BIOVENTRIX, INC.
Ticker: 
CIK: 1283259
Filing Type: S-1/A
Document Type: S-1/A
Date Filed: 2026-05-15
Accession Number: 0001493152-26-023752
Exchange: 
SIC Code: 3841
SIC Description: Surgical & Medical Instruments & Apparatus
URL: https://www.sec.gov/Archives/edgar/data/1283259/000149315226023752/forms-1a.htm

Chunk 23 of 94
Word Count: 1292
Character Count: 8379

Document Content:

and competitive position. Our ability to enforce our patent rights depends on our ability to detect infringement. It may be difficult to detect infringers who do not advertise the use of infringing product candidates, the practice of infringing methods, or the incorporation of infringing components in their product candidates. It may be difficult or impossible to obtain evidence of infringement in a competitor’s or potential competitor’s product, or infringing uses or sales by a customer of a competitor. We may not prevail in any lawsuits that we initiate, and the damages or other remedies awarded if we were to prevail may not be commercially meaningful. In addition, third parties may attempt to commercialize competitive product candidates or methods in foreign countries where we do not have any patents or patent applications and/or where legal recourse may be limited. This may have a significant commercial impact on our foreign business operations.

addition, proceedings to enforce or defend our patents could put our patents at risk of being invalidated, held unenforceable or interpreted
narrowly. Such proceedings could also provoke third parties to assert claims against us, including that some or all of the claims in
one or more of our patents are invalid or otherwise unenforceable. If any of our patents covering our product candidates, product candidates,
or methods are invalidated or found unenforceable, our financial position and results of operations could be negatively impacted. In
addition, if a court finds that valid, enforceable patents held by third parties cover one or more of our product candidates, product
candidates, or methods, our financial position and results of operations could be harmed.

rely upon unpatented trade secrets, unpatented know-how and continuing technological innovation to develop and maintain our competitive
position, which we may seek to protect, in part, by entering into confidentiality agreements with our employees, suppliers, vendors,
collaborators, and/or consultants. We may not be able to prevent the unauthorized disclosure or use of our technical knowledge or trade
secrets by consultants, suppliers, vendors, former employees and current employees. If parties to any such agreements breach or violate
the terms of any such agreements, we may not have adequate remedies for the breach or violation, and we could lose our trade secrets
through the breach or violation. Also, it is possible that technology relevant to our business will be independently developed by a person
that is not a party to such an agreement. Further, our trade secrets could otherwise become known or be independently discovered by our
competitors, which could diminish the value and competitive worth of those trade secrets.

we fail to comply with our obligations in the agreements under which we may license intellectual property rights from third parties or
otherwise experience disruptions to our business relationships with our licensors, we could lose rights that are important to our business.

have licensed and may enter into or may be required to enter into intellectual property license agreements that are important to our
business. These license agreements may impose various diligence, milestone, payment, royalty and other obligations on us. For example,
we may enter into exclusive license agreements with various universities and research institutions, we may be required to use commercially
reasonable efforts to engage in various development and commercialization activities with respect to licensed product candidates, and
may need to satisfy specified milestone and royalty payment obligations. If we fail to comply with any obligations under our agreements
with any of these licensors, we may be subject to termination of the license agreement in whole or in part, increased financial obligations
to our licensors or loss of exclusivity in a particular field or territory, in which case our ability to develop or commercialize product
candidates covered by the license agreement will be impaired.

addition, disputes may arise regarding intellectual property subject to a license agreement, including:

●	the
scope of rights granted under the license agreement and other interpretation-related issues;

●	the
extent to which our processes infringe on intellectual property of the licensor that is not subject to the licensing agreement;

●	our
diligence obligations under the license agreement and what activities satisfy those obligations;

a third-party expresses interest in an area under a license that we are not pursuing, under the terms of certain of our license agreements,
we may be required to sublicense rights in that area to the third party, and that sublicense could harm our business; and

●	the
ownership of inventions and know-how resulting from the joint creation or use of intellectual property by our licensors and us.

Disputes
over intellectual property that we have licensed may prevent or impair our ability to maintain our current licensing arrangements on
acceptable terms, and we may be unable to successfully develop and commercialize our product candidates.

Obtaining
and maintaining our patent protection is a complex process that requires compliance with various procedures, documentation requirements,
fee payments and other requirements imposed by governmental patent agencies, and our patent protection could be reduced or eliminated
for non-compliance with these requirements.

The
patent prosecution process is expensive, time-consuming and complex, and we may not be able to file, prosecute, maintain, enforce or
license all necessary or desirable patent applications at a reasonable cost or in a timely manner. It is also possible that we will fail
to identify patentable aspects of our research and development output in time to obtain patent protection. Also, filing, prosecuting
and defending patents on our product candidates in all countries throughout the world would be prohibitively expensive. Consequently,
we may not be able to prevent third parties from practicing our inventions in all countries outside the United States, or from selling
or importing product candidates made using our inventions in and into the United States or other jurisdictions.

There
can be no guarantee that any patents will issue from our pending patent applications or future patent applications that we file, if any,
and there can be no guarantee that any issued patents will adequately protect our intellectual property. We cannot be certain that we
were the first to make the inventions claimed in any of our patents or pending patent applications, or that we were the first to file
for patent protection for such inventions. Defects of form in the preparation or filing of our patents or patent applications may exist,
or may arise in the future, for example, with respect to proper priority claims, inventorship and the like. If there are material defects
in the form, preparation or prosecution of our patents or patent applications, such patents or applications may be invalid and unenforceable.
Any of these outcomes could impair our ability to prevent competition from third parties, which may have an adverse impact on our business.

The
legal standards relating to the validity, enforceability and scope of protection of patent and other intellectual property rights are
complex and often uncertain, and are subject to change that can affect the validity of patents issued under previous legal standards.
The U.S. Patent and Trademark Office, or USPTO, and various foreign governmental patent agencies further require compliance with a number
of procedural, documentary, fee payments (e.g., maintenance and annuity fee payments), and other provisions during the patent procurement
process as well as over the life span of an issued patent. Noncompliance can result in abandonment or lapse of a patent or patent application,
resulting in partial or complete loss of patent rights in the relevant jurisdiction. In such an event, competitors might be able to enter
the market or compete more directly at an earlier time than would otherwise have been the case.

may incur substantial costs as a result of litigation or other proceedings relating to patent and other intellectual property rights
and we may be unable to protect our rights to, or use of, our technology.